In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.

about

Treatment and prevention of infective endocarditis.Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome.Bioactive oligosaccharide natural products.

P2860

Q34519242-ECC085F8-06D1-4E7E-B517-5976FBA67A54 Q37086516-5D997129-84C2-4F3F-A6AD-DB6B08A406D8 Q38216655-C1225E63-ACEC-4D30-9E29-0A95A2EE18F6

P2860

In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.

Item

http://www.wikidata.org/entity/Q39475968

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

In vivo activity of evernimici ...... mental infective endocarditis.

@en

In vivo activity of evernimicin

@nl

type

Item

label

In vivo activity of evernimici ...... mental infective endocarditis.

@en

In vivo activity of evernimicin

@nl

prefLabel

In vivo activity of evernimici ...... mental infective endocarditis.

@en

In vivo activity of evernimicin

@nl

P1476

In vivo activity of evernimici ...... mental infective endocarditis.

@en

P2093

C Thauvin-Eliopoulos

http://www.w3.org/2001/XMLSchema#string

D Loebenberg

http://www.w3.org/2001/XMLSchema#string

G M Eliopoulos

http://www.w3.org/2001/XMLSchema#string

H W Boucher

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.

In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.

Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.

In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.

Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.

Rat model of experimental endocarditis

Antimicrobial-drug resistance.

Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary.

P304

208-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.1.208-211.2001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11120967

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

90262

http://www.w3.org/2001/XMLSchema#string

In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.

about

P2860

P2860

In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932